Ancora Advisors’s Healthpeak Properties DOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$45.6K Buy
2,773
+1,020
+58% +$17.5K ﹤0.01% 1177
2025
Q4
$28.2K Buy
1,753
+1,330
+314% +$23.4K ﹤0.01% 1384
2025
Q3
$8.1K Hold
423
﹤0.01% 1426
2025
Q2
$7.41K Buy
423
+297
+236% +$5.28K ﹤0.01% 1422
2025
Q1
$2.55K Hold
126
﹤0.01% 1501
2024
Q4
$2.55K Buy
+126
New +$2.73K ﹤0.01% 1535
2022
Q3
Sell
-500
Closed -$13K 2077
2022
Q2
$13K Hold
500
﹤0.01% 1533
2022
Q1
$17K Hold
500
﹤0.01% 1585
2021
Q4
$18K Hold
500
﹤0.01% 1619
2021
Q3
$17K Hold
500
﹤0.01% 1528
2021
Q2
$17K Hold
500
﹤0.01% 1393
2021
Q1
$16K Hold
500
﹤0.01% 1348
2020
Q4
$15K Hold
500
﹤0.01% 1119
2020
Q3
$14K Hold
500
﹤0.01% 1075
2020
Q2
$14K Hold
500
﹤0.01% 1046
2020
Q1
$12K Hold
500
﹤0.01% 1146
2019
Q4
$17K Buy
+500
New +$17.5K ﹤0.01% 1089
2018
Q4
Sell
-500
Closed -$13K 752
2018
Q3
$13K Buy
+500
New +$13.1K ﹤0.01% 1151
2017
Q1
Sell
-1,050
Closed -$31K 716
2016
Q4
$31K Buy
+1,050
New +$32K ﹤0.01% 851

Other funds holding DOC

Ancora Advisors's DOC Position: Q1 2026 in Review

Ancora Advisors increased its Healthpeak Properties (DOC) stake by 58% in Q1 2026, buying an estimated $17.5K and bringing the position to 2,773 shares worth $45.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1177.

Ancora Advisors first reported a position in DOC in Q4 2016 and has held it in 19 quarters since. 756 funds tracked by Wall St. Rank hold DOC as of Q1 2026.

  • Ancora Advisors held 2,773 shares of Healthpeak Properties worth $45.6K as of Q1 2026.
  • Ancora Advisors bought 1,020 Healthpeak Properties shares in Q1 2026, an estimated $17.5K.
  • Healthpeak Properties made up ﹤0.01% of Ancora Advisors's portfolio in Q1 2026, its #1177 holding.
  • Ancora Advisors first reported a position in Healthpeak Properties in Q4 2016 and has held it in 19 quarters since.
  • 756 funds tracked by Wall St. Rank held Healthpeak Properties as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.